In this experimental CAN model, long-term TSP-2 gene therapy resulted in worsened renal capillary rarefaction via direct or potentially indirect inhibition of endothelial cell proliferation. This evidence concerns the gene THBS2 and Crouzon syndrome-acanthosis nigricans syndrome.